HPQ Silicon Advances Fumed Silica Plant with $20M Joint Venture
Event summary
- HPQ Silicon's subsidiary HSPI signs non-binding MOU for a $20M commercial fumed silica plant with an undisclosed strategic partner.
- The 1,000-tonne-per-year facility will be designed and built by PyroGenesis using HSPI’s proprietary plasma-based Fumed Silica Reactor (FSR) technology.
- HSPI to receive recurring royalties on each kilogram of fumed silica sold under an offtake arrangement with the strategic partner.
- Final agreements contingent on third-party testing and validation, expected by Q2 2026.
The big picture
HPQ Silicon’s joint venture marks a strategic shift toward commercializing its proprietary fumed silica technology, aligning with broader industry trends in advanced materials and sustainable manufacturing. The $20M project, if successful, could establish a scalable platform for recurring revenues while reducing capital exposure. Fumed silica’s critical role in industries like cosmetics, pharmaceuticals, and construction underscores the market potential.
What we're watching
- Technical Validation
- Whether third-party testing confirms the chemical and compositional characteristics required for commercial applications.
- Execution Risk
- The pace at which definitive agreements are finalized and construction begins, given the non-binding nature of the MOU.
- Scalability Potential
- How successfully deploying this initial plant will position HPQ to replicate the model across multiple sites as demand grows.
Related topics